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Hypoxia, or reduced of oxygen pressure, in healthy cells leads to cell necrosis and reoxygenation 
injuries; however, hypoxia is a prominent property of most solid tumors. The low oxygen 
pressure in cells activates the hypoxia-inducible factor (HIF) family of transcription factors, 
which induce targets genes that regulates adaptive biological processes such as anaerobic 
metabolism, cell motility and angiogenesis1. Overexpression of HIF-1α, a subunit of the HIF 
complex, has been linked to metastasis of tumor cells, and resistance to radio and chemotherapy.  
Because of this, HIF-1 has become an important therapeutic target for the inhibition of tumor 
growth by small molecules. It is our goal to design and synthesize novel small-molecules that 
disrupts HIF pathway mainly by targeting the HIF-1α subunit to prevent it from binding with the 
HIF-1β subunit that makes the HIF heterodimer and initiate its biochemical activity as a 
transcription factor that promote tumor cell growth.  Mechanistic studies shows that these novel 
inhibitors do not primarily alter HIF-1 levels rather, they interfere with the HIF complex 
formation1. An initial HRE-alkaline phosphatase assay screening was done to find a lead 
compound.  
A compound (KCN-1) with an IC50 of 0.4µM was 
tested and was found to be very potent in 
decreasing tumor size. Optimization of the said 
compound was subsequently done by dividing the 
compound into 4 parts (cores) and analogues have 
been made; the best compound made to date has 
an IC50 of 0.25µM. 
 
References: 
1. Mooring, S.R.; Jin, H.; Devi, N.S.; Jabbar, A.A.; Kaluz, S.; Liu, Y.; Van Meir, E.G.; 
Wang,  B., Design and Synthesis of Novel Small-Molecule Inhibitors of the Hypoxia 
Inducible  Factor Pathway. Journal of Medicinal Chemistry 2011 54 (24), 8471-
8489. 
 
Figure 1 Molecular Structure of KCN-1 
